Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: A real clinical entity? [5]

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1893-1895

  Tarng, D C ^a   Huang, T P ^a   Chen, T W ^a   Fan, C Y ^a   Chang, J G ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; CLINICAL ARTICLE; DRUG COST; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA;

EID: 0029795261     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027700     Document Type: Letter

References (0)